TGFB1 and nasal cavity polyp: TGF-β1 signaling acts as a potent driver in EMT during nasal polyp formation and growth, inducing a loss of epithelial and gain of mesenchymal markers, verified by TSA, HDAC 1/2 inhibitor [35].